ISPOR - Session

A Propensity Score-Based Comparison of Tepotinib Versus Immunotherapy with/without Chemotherapy, Using Real-World Data in Previously Untreated Met Exon 14 (METEX14) Skipping Non‑Small Cell Lung Cancer (NSCLC)

Nov 15, 2023, 09:00 AM